Novo Nordisk launched a consumer campaign for Victoza, emphasizing the product’s ability to bring down blood sugar levels and body weight in patients with type 2 diabetes. The campaign features print ...

BARCELONA—Novo Nordisk’s Ozempic is off to a blazing start, and the company just threw more fuel on the fire with a pair of trial wins. Ozempic (semaglutide) topped both SGLT2 drug Invokana from ...

Unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-1 weight loss products, Novo Nordisk is employing a new strategy—reducing production of diabetes drug Victoza ...

Hikma recently received the Food and Drug Administration’s permission for a new generic, and the company also launched two new generic products. The FDA approved Hikma's first generic referencing ...

Branded content furnished by our promotional partners. The Daily Sundial editorial staff is not involved in its production. Content does not reflect the views or opinions of the editorial staff.

The Food and Drug Administration (FDA) approval was based on data from the randomized, double-blind, placebo-controlled LEADER trial (n=9,340) that evaluated long-term effects of Victoza vs. placebo ...

The US Food and Drug Administration (FDA) approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes. Victoza is the first non-insulin drug ...

Victoza (liraglutide) is a prescription drug that’s used to manage high blood sugar in certain adults and children with type 2 diabetes. Victoza can interact with some supplements and with other drugs ...

COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk said two patients in Japan who were being treated with its Victoza type-2 diabetes drug died from the discontinuation of their insulin treatment ...